Tuesday, April 6, 2021

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

Although the Global Position Statement endorses testosterone therapy for only postmenopausal women, limited data also support the use in late reproductive age premenopausal women, consistent with the International Society for the Study of Women's Sexual Health Process of Care for the Management of HSDD. Systemic transdermal testosterone is recommended for women with HSDD not primarily related to modifiable factors or comorbidities such as relationship or mental health problems. 



https://www.liebertpub.com/doi/10.1089/jwh.2021.29037?utm_source=Adestra&utm_medium=email&utm_term=&utm_content=read1&utm_campaign=JWH%20FP%20APR%206%202021

5 comments:

  1. https://ukthestudy.blogspot.com/2012/12/while-youre-away-keep-your-home-safe.html?showComment=1630143046693#c2917916421011932076

    ReplyDelete
  2. This is also a very good post which I really
    enjoyed reading. It is not every day that I have the possibility to see
    something like this.. Dream Interpretation

    ReplyDelete
  3. Thanks for the informative and helpful post, obviously in your blog everything is good.. 알파벳 토토

    ReplyDelete
  4. This was a very interesting post. Thanks for all the information. Keep up the good work. fitmania

    ReplyDelete

It is your (Households and Consumers) Turn

MY MORE THAN 20 YEARS OF MODERN SELFCARE HEALTHY STRUCTURAL SUCCESS IS A NEW GLOBAL HEALTH, DEVELOPMENT, AND TRIUMPHANT LIVING AS A CULTURE ...